PG-Seq™ rapid non-invasive preimplantation genetic testing kit: An alternative to IVF embryo biopsies
New kit from PerkinElmer shown to achieve over 90% correlation rate between biopsied embryos and testing spent culture media
New kit from PerkinElmer shown to achieve over 90% correlation rate between biopsied embryos and testing spent culture media
Grant received to use the Mission Bio Tapestri Platform to improve the measurement of residual cancerous cells remaining post-treatment
Designed specifically for smaller biobanks the BB package simplifies sample integrity, tracking and audit trail.
Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer
We celebrate the clinical laboratory products that have made the most difference to your lab work or point-of-care testing and reveal our most popular clinical content of the year
Discover the latest technology for the identification of structural variants (SVs) within the human genome
Drop by and see SelectScience on booth #724 at this year's AACC conference in Anaheim, California, from August 4-8
Partnership strengthens IDT’s position as an NGS leader in China
Japan selects QIAGEN Clinical Insight-Interpret to handle next-generation sequencing data
Help us celebrate the best new clinical assays, kits, instruments and devices by casting your vote today
Dr. Luca Quagliata explains how molecular profiling could transform the way we treat cancer, and how his work is enabling the global adoption of this technology – in the face of clinical challenges and diversity
Don’t miss April’s highlights thanks to our regular monthly round-up of all the most popular stories and resources in the clinical science community
This new solution could enable large-scale AAV vector production for gene therapy
Catch up on all the biggest stories and top downloadable content in the clinical community in our monthly round-up
Scientists from the esteemed Institute for Genetic Medicine, Newcastle, UK, are using sophisticated consumable technologies to advance research into rare mitochondrial diseases
Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes
We asked you how science would change the world in the next 20 years – here's what you said
DNA from 15,000 patients analyzed to identify novel genetic associations
Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition
New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission